BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20007405)

  • 1. Naturally occurring variants of human CBR3 alter anthracycline in vitro metabolism.
    Bains OS; Karkling MJ; Lubieniecka JM; Grigliatti TA; Reid RE; Riggs KW
    J Pharmacol Exp Ther; 2010 Mar; 332(3):755-63. PubMed ID: 20007405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two nonsynonymous single nucleotide polymorphisms of human carbonyl reductase 1 demonstrate reduced in vitro metabolism of daunorubicin and doxorubicin.
    Bains OS; Karkling MJ; Grigliatti TA; Reid RE; Riggs KW
    Drug Metab Dispos; 2009 May; 37(5):1107-14. PubMed ID: 19204081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naturally occurring variants of human aldo-keto reductases with reduced in vitro metabolism of daunorubicin and doxorubicin.
    Bains OS; Grigliatti TA; Reid RE; Riggs KW
    J Pharmacol Exp Ther; 2010 Dec; 335(3):533-45. PubMed ID: 20837989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two allelic variants of aldo-keto reductase 1A1 exhibit reduced in vitro metabolism of daunorubicin.
    Bains OS; Takahashi RH; Pfeifer TA; Grigliatti TA; Reid RE; Riggs KW
    Drug Metab Dispos; 2008 May; 36(5):904-10. PubMed ID: 18276838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldo-keto reductase 1C2 fails to metabolize doxorubicin and daunorubicin in vitro.
    Takahashi RH; Bains OS; Pfeifer TA; Grigliatti TA; Reid RE; Riggs KW
    Drug Metab Dispos; 2008 Jun; 36(6):991-4. PubMed ID: 18322072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the binding of daunorubicin and doxorubicin to NADPH-dependent cytosolic reductases by computational methods.
    Pirolli D; Giardina B; Mordente A; Ficarra S; De Rosa MC
    Eur J Med Chem; 2012 Oct; 56():145-54. PubMed ID: 22982121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A correlation between cytotoxicity and reductase-mediated metabolism in cell lines treated with doxorubicin and daunorubicin.
    Bains OS; Szeitz A; Lubieniecka JM; Cragg GE; Grigliatti TA; Riggs KW; Reid RE
    J Pharmacol Exp Ther; 2013 Nov; 347(2):375-87. PubMed ID: 23995598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anthracyclines and their metabolism in human liver microsomes and the participation of the new microsomal carbonyl reductase.
    Skarka A; Skarydová L; Stambergová H; Wsól V
    Chem Biol Interact; 2011 May; 191(1-3):66-74. PubMed ID: 21185270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotype of human carbonyl reductase CBR3 correlates with doxorubicin disposition and toxicity.
    Fan L; Goh BC; Wong CI; Sukri N; Lim SE; Tan SH; Guo JY; Lim R; Yap HL; Khoo YM; Iau P; Lee HS; Lee SC
    Pharmacogenet Genomics; 2008 Jul; 18(7):621-31. PubMed ID: 18551042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional significance of a natural allelic variant of human carbonyl reductase 3 (CBR3).
    Lakhman SS; Ghosh D; Blanco JG
    Drug Metab Dispos; 2005 Feb; 33(2):254-7. PubMed ID: 15537833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H:quinone oxidoreductase 1 gene NQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer.
    Blanco JG; Leisenring WM; Gonzalez-Covarrubias VM; Kawashima TI; Davies SM; Relling MV; Robison LL; Sklar CA; Stovall M; Bhatia S
    Cancer; 2008 Jun; 112(12):2789-95. PubMed ID: 18457324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver.
    Kassner N; Huse K; Martin HJ; Gödtel-Armbrust U; Metzger A; Meineke I; Brockmöller J; Klein K; Zanger UM; Maser E; Wojnowski L
    Drug Metab Dispos; 2008 Oct; 36(10):2113-20. PubMed ID: 18635746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary alcohol metabolites mediate iron delocalization in cytosolic fractions of myocardial biopsies exposed to anticancer anthracyclines. Novel linkage between anthracycline metabolism and iron-induced cardiotoxicity.
    Minotti G; Cavaliere AF; Mordente A; Rossi M; Schiavello R; Zamparelli R; Possati G
    J Clin Invest; 1995 Apr; 95(4):1595-605. PubMed ID: 7706466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the Canine Anthracycline-Metabolizing Enzyme Carbonyl Reductase 1 (cbr1) and the Functional Isoform cbr1 V218.
    Ferguson DC; Cheng Q; Blanco JG
    Drug Metab Dispos; 2015 Jul; 43(7):922-7. PubMed ID: 25918240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes--a report from the Children's Oncology Group.
    Blanco JG; Sun CL; Landier W; Chen L; Esparza-Duran D; Leisenring W; Mays A; Friedman DL; Ginsberg JP; Hudson MM; Neglia JP; Oeffinger KC; Ritchey AK; Villaluna D; Relling MV; Bhatia S
    J Clin Oncol; 2012 May; 30(13):1415-21. PubMed ID: 22124095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-nucleotide polymorphisms in aldo-keto and carbonyl reductase genes are not associated with acute cardiotoxicity after daunorubicin chemotherapy.
    Lubieniecka JM; Liu J; Heffner D; Graham J; Reid R; Hogge D; Grigliatti TA; Riggs WK
    Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):2118-20. PubMed ID: 23001242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the stability of doxorubicin and daunorubicin in solid state.
    Cielecka-Piontek J; Jelińska A; Zajac M; Sobczak M; Bartold A; Oszczapowicz I
    J Pharm Biomed Anal; 2009 Nov; 50(4):576-9. PubMed ID: 19195811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naturally occurring variations in the human 5-HT3A gene profoundly impact 5-HT3 receptor function and expression.
    Krzywkowski K; Jensen AA; Connolly CN; Bräuner-Osborne H
    Pharmacogenet Genomics; 2007 Apr; 17(4):255-66. PubMed ID: 17496724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of allelic variation in aldo-keto reductase 1C2 on the in vitro metabolism of dihydrotestosterone.
    Takahashi RH; Grigliatti TA; Reid RE; Riggs KW
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1032-9. PubMed ID: 19258517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the role of the amino acid residue at position 230 for catalysis in monomeric carbonyl reductase 3.
    Miura T; Itoh Y; Takada M; Tsutsui H; Yukimura T; Nishinaka T; Terada T
    Chem Biol Interact; 2009 Mar; 178(1-3):211-4. PubMed ID: 18983987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.